1-3 of 3
Brandi O'Neal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy

Clinical Trials & Observations
Susan O'Brien, Farhad Ravandi, Todd Riehl, William Wierda, Xuelin Huang, Jeffrey Tarrand, Brandi O'Neal, Hagop Kantarjian, Michael Keating
Journal: Blood
Blood (2008) 111 (4): 1816–1819.
https://doi.org/10.1182/blood-2007-03-080010
Published: 2008
Journal Articles

Fludarabine, Cyclophosphamide, Mitoxantrone Plus Rituximab (FCM-R) as Frontline Therapy for CLL: Results of a Phase 2 Study.

Stefan Faderl, MD, William G. Wierda, MD PhD, Susan O’Brien, MD, Alessandra Ferrajoli, MD, Farhad Ravandi-Kashani, MD, Michelle Detry, PhD, Hagop M. Kantarjian, MD, Brandi O’Neal, RN, Michael J. Keating, MB BS
Journal: Blood
Blood (2006) 108 (11): 2836.
https://doi.org/10.1182/blood.V108.11.2836.2836
Published: 2006
Journal Articles

Rituximab Plus GM-CSF for Patients with Chronic Lymphocytic Leukemia.

Alessandra Ferrajoli, MD, Susan M. O’Brien, MD, Stefan H. Faderl, MD, William G. Wierda, MD, PhD, Farhad Ravandi-Kashani, M.B.BS, Brandi O’Neal, BSN, Ellen Schlette, MD, Maher Albitar, MD, Hagop M. Kantarjian, MD, Michael J. Keating, M.B.BS
Journal: Blood
Blood (2005) 106 (11): 721.
https://doi.org/10.1182/blood.V106.11.721.721
Published: 2005